The stocks of BABA have been presented with a rating of buy by close to twenty-eight researchers that have been covering the stocks. According to reports, two of the research equities involved with the firm have presented the stocks with a rating of hold, while twenty-one of them have given the stocks a rating of buy. Currently, the target price of BABA over a period of one year has been set at $319.78.
The Quarterly Estimates of BABA
There have been quite a few research firms that have already commented on the stocks of BABA. Zacks Investment Research has already issued the rating of the company from buy to hold, along with a price target of $280. Oppenheimer decided to go the other way, with a price target increased from $325 to $335, along with a rating of outperform. This was then published in a 26th November research report. Truist also went the same way, with a price target increased from $308 to $326, along with Benchmark who increased the price target from $290 to $355. In the end, Robert W. Baird also increased the price range from $275 to $325 in a 30th September research note.
The stocks of BABA traded on Friday at $258.62. The market cap of the firm is $699.73 billion, with a 37.10 PE ratio and a 1.59 PEG ratio. The moving average price of the company over 50-days has been set at $246.02, along with the price over 200-days that was set at $267.86. The year low of the firm was $169.95, while the year high has been set at $319.32.
The company did post its quarterly updates on the 5th of November. The EPS reported by BABA over the quarter was $17.97, which was comprehensively more than the consensus estimate of about $1.69.